Skip to main content

Table 2 Surgical and postoperative pathologic information of the patients with oesophageal cancer

From: Advantages of McKeown minimally invasive oesophagectomy for the treatment of oesophageal cancer: propensity score matching analysis of 169 cases

Clinical variables MIE group (n= 169) OE group (n=169) P
Substitution type    <0.01
 Entire stomach 0 169 (100%)  
 Gastric tube 169 (100%) 0  
Anastomotic type    <0.01
 Cervical anastomosis 169 (100%) 0  
 Intrathoracic anastomosis 0 169 (100%)  
Omentoplasty    <0.01
 Yes 169 (100%) 0  
 No 0 169 (100%)  
Histologic type    0.100
 Squamous cell carcinoma 162 (95.9%) 148 (87.6%)  
 Adenocarcinoma 3 (1.8%) 10 (5.9%)  
 Adenosquamous carcinoma 3 (1.8%) 5 (3.0%)  
 Neuroendocrine carcinoma 0 (0.0%) 2 (1.2%)  
 Small cell carcinoma 1 (0.6%) 2 (1.2%)  
 Sarcoma 0 (0.0%) 2 (1.2%)  
Tumour size (mean ± SD, cm) 4.78 ± 2.17 4.80 ± 2.05 0.879
T stage    0.314
 T1 21 (12.4%) 20 (11.8%)  
 T2 47 (27.8%) 49 (29.0%)  
 T3 100 (59.2%) 82 (48.5%)  
 T4 1 (0.6%) 18 (10.7%)  
N stage    0.974
 N0 105 (62.1%) 104 (61.5%)  
 N1 53 (31.4%) 54 (32.0%)  
 N2 7 (4.1%) 8 (4.7%)  
 N3 4 (2.4%) 3 (1.8%)